RTOG GU Radiation Oncology Specialists Reach Consensus on Pelvic Lymph Node Volumes for High-Risk Prostate Cancer

International Journal of Radiation Oncology Biology Physics

Volumn 74, Issue 2, 2009, Pages 383-387

  Lawton, Colleen A F ^a   Michalski, Jeff ^b   El Naqa, Issam ^c   Buyyounouski, Mark K ^d   Lee, W Robert ^e   Menard, Cynthia ^f   O'Meara, Elizabeth ^g   Rosenthal, Seth A ^h   Ritter, Mark ⁱ   Seider, Michael ^j  

^a MEDICAL COLLEGE OF WISCONSIN   (United States)

^b WASHINGTON UNIVERSITY   (United States)

^c WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d FOX CHASE CANCER CENTER   (United States)

^e WAKE FOREST SCHOOL OF MEDICINE   (United States)

^f UNIVERSITY OF TORONTO   (Canada)

^g AMERICAN COLLEGE OF RADIOLOGY   (United States)

^h Radiological Associates of Sacramento Medical Group Inc   (United States)

ⁱ UNIVERSITY OF WISCONSIN SCHOOL OF MEDICINE AND PUBLIC HEALTH   (United States)

^j AKRON CITY HOSPITAL   (United States)

more..

Author keywords

IMRT; Pelvic lymph nodes; Prostate cancer; Radiation oncology guidelines; Target volume

Indexed keywords

IMRT; PELVIC LYMPH NODES; PROSTATE CANCER; RADIATION ONCOLOGY GUIDELINES; TARGET VOLUME;

BONE; COMPUTERIZED TOMOGRAPHY; ONCOLOGY; PHYSICAL THERAPY; RADIATION; RADIOTHERAPY; TARGETS; TOMOGRAPHY; TUMORS;

BODY FLUIDS;

ARTERY; ARTICLE; BLADDER; COMPUTER ASSISTED TOMOGRAPHY; CONSENSUS DEVELOPMENT; DISTAL COMMON ILIAC LYMPH NODE; EXTERNAL ILIAC LYMPH NODE; HISTOGRAM; HUMAN; ILIAC BONE; IMAGE ANALYSIS; INTERNAL ILIAC LYMPH NODE; LYMPH NODE METASTASIS; MEDICAL SOCIETY; MEDICAL SPECIALIST; MUSCLE; NORMAL HUMAN; OBTURATOR LYMPH NODE; ONCOLOGY; PELVIS LYMPH NODE; PRACTICE GUIDELINE; PRESACRAL LYMPH NODE; PRIORITY JOURNAL; PROSTATE CANCER; PUBIC BONE; SACRUM; VEIN;

HUMANS; LYMPH NODE EXCISION; LYMPH NODES; LYMPHATIC IRRADIATION; MALE; PELVIS; PROSTATIC NEOPLASMS; RADIATION ONCOLOGY; RADIOTHERAPY DOSAGE; RECTUM; TOMOGRAPHY, X-RAY COMPUTED; URINARY BLADDER; UROLOGY;

EID: 67349188234     PISSN: 03603016     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijrobp.2008.08.002     Document Type: Article

References (24)

1. Pilepich M., Winter K., Lawton C., et al. Androgen suppression adjuvant to definitive radiotherapy in prostate carcinoma long term results of phase III RTOG 85-31. Int J Radiat Oncol Biol Phys 61 5 (2005) 1285-1290
2. Roach III M., Bae K., Speight J., et al. Short term neoadjuvant androgen deprivation therapy and external beam radiotherapy for locally advanced prostate cancer: long term results of RTOG 8610 a Phase III prospective randomized trial. J Clin Oncol 26 4 (2008) 585-591
3. Horwitz E., Bae K., Hanks G., et al. Ten-year follow-up of RTOG 92-02: a phase III trial of the duration of elective androgen deprivation in locally advanced prostate cancer. J Clin Oncol 26 (2008) 2497-2504
4. Bolla M., Collette L., Blank L., et al. Long term results with immediate androgen suppression and external irradiation in patients with locally advanced prostate cancer (an EORTC study, a phase III randomized trial). Lancet 360 (2002) 103-108
5. Roach III M., DeSilvio M., Valicenti R., et al. Whole-pelvis, "mini-pelvis," or prostate-only external beam radiotherapy after neoadjuvant and concurrent hormonal therapy in patients treated in the Radiation Therapy Oncology Group 9413 trial. Int J Radiat Oncol Biol Phys 66 3 (2006) 647-653
6. RTOG 05-21: A phase III protocol of androgen suppression (AS) and 3D CRT/IMRT vs AS and 3D CRT/IMRT followed by chemotherapy with docetaxel and prednisone for localized high risk prostate cancer. Available at: http://rtog.org. Accessed September 10, 2008.
7. RTOG 05-34: A phase III trial of short term androgen deprivation with pelvic lymph node or prostate bed only radiotherapy (SPPORT) in prostate cancer patients with a rising PSA after radical prostatectomy. Available at: http://rtog.org. Accessed September 10, 2008.
8. Lawton C.A., Michalski J., El-Naqa I., et al. Variation in the definition of clinical target volumes for pelvic node conformal radiation therapy of prostate cancer. [abstract 2224]. Int J Radiat Oncol Biol Phys 69 3 Suppl (2007) S327
9. Raghavalah N.V., and Jordan Jr. W.P. Prostatic lymphography. J Urol 121 (1979) 178-181
10. Cerny J.C., Farah R., Rian R., et al. An evaluation of lymphangiography in staging carcinoma of the prostate. J Urol 113 (1975) 367-370
11. Golimbu M., Morales P., Al-Askari S., et al. Extended pelvic lymphadenectomy for prostate cancer. J Urol 121 (1979) 617-620
12. Bader P., Burkhard F., Markwalder R., et al. Is a limited node dissection an adequate staging procedure for prostate cancer?. J Urol 168 (2002) 514-518
13. Burkhard F., Schumacker M., Thalmann G.N., et al. Is pelvic lymphadenectomy really necessary in patients with a serum prostate-specific antigen level of <10 ng/ml undergoing radical prostatectomy for prostate cancer?. BJU Int 95 (2005) 275-280
14. Heidenreich A., Varga Z., and Von Knobloch R. Extended pelvic lymphadenectomy in patients undergoing radical prostatectomy: high incidence of lymph node metastasis. J Urol 167 (2002) 1681-1686
15. Allaf M., Palapattu G., Trock G., et al. Anatomical extent of lymph node dissection: Impact on men with clinically localized prostate cancer. J Urol 172 (2004) 1840-1844
16. Wawroschek F., Vogt H., Weckermann D., et al. The sentinel lymph node concept in prostate cancer: First results of gamma probe-guided sentinel lymph node identification. Eur Urol 36 (1999) 595-600
17. Takashima H., Egawa M., Imao T., et al. Validity of sentinel lymph node concept for patients with prostate cancer. J Urol 171 (2004) 2268-2271
18. Weckermann D., Dorn R., Trefz M., et al. Sentinel lymph node dissection for prostate cancer: Experience with more than 1,000 patients. J Urol 177 (2007) 916-920
19. Netter F. Atlas of human anatomy. 2nd ed (1997), Novartis, East Hanover, NJ p. 379
20. Gil-Vernet J.M. Prostate cancer: anatomical and surgical considerations. Br J Urol 78 (1996) 161-168
21. Shih H., Harisinghani M., Zietman A., et al. Mapping of nodal disease in locally advanced prostate cancer: Rethinking the clinical target volume for pelvic nodal irradiation based on vascular rather than bony anatomy. J Int Radiat Oncol Biol Phys 63 4 (2005) 1262-1269
22. Taylor A., Rockall A., Reznek R., et al. Mapping pelvic lymph nodes: Guidelines for delineation in intensity modulated radiotherapy. J Int Radiat Oncol Biol Phys 63 5 (2005) 1604-1612
23. American Cancer Society. Cancer facts and figures 2007 (2007), American Cancer Society, Atlanta
24. Small Jr. W., Mell L.K., Anderson P., et al. Consensus guidelines for the delineation of the clinical target volume for intensity modulated pelvic radiotherapy in the postoperative treatment of endometrial and cervical cancer. J Int Radiat Oncol Biol Phys 71 2 (2008) 428-434